Article Information
- Received March 14, 2003
- Revision received April 24, 2003
- Accepted April 28, 2003
- First published July 2, 2003.
- Version of record published July 2, 2003.
Author Information
Author contributions
Disclosures
- Received March 14, 2003.
- Revision received April 24, 2003.
- Accepted April 28, 2003.
This research was supported by grants from the National Institutes of Health (D.S.B. and R.A.N.), the Christopher Reeves Paralysis Foundation (D.S.B.), the Human Frontier Research Program (D.S.B.), and the Bristol-Myers Squibb Company (R.A.N.). V.S. is supported by a grant from the Deutsche Forschungsgemeinschaft (Emmy Noether Programm). R.A.N. is a member of the Keck Center for Integrative Neuroscience and the Silvo Conte Center for Neuroscience Research. D.S.B. is an established investigator for the American Heart Association.
Correspondence should be addressed to Roger A. Nicoll, Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94143.
Copyright © 2003 Society for Neuroscience 0270-6474/03/235503-04$15.00/0
Online Impact
Article usage
In this issue
